Evidence map›Paper›PMID 41708138›Full record

ArticleBMJ global health2026

Chikungunya clinical management guidance: insights from a health system stakeholder study in Indonesia.

Evi Sukmaningrum, Komang Ayu Kartika Sari, Theresia Puspoarum Kusumoputri, Ni Luh Putu Ariastuti, Kevin Kristian, Eric Sindunata, Hendry Luis, Pande Putu Januraga, Peter W Horby, Louise Sigfrid and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ global health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Evi SukmaningrumFaculty of Psychology, Atma Jaya Catholic University of Indonesia, South Jakarta, DKI Jakarta, Indonesia.
Komang Ayu Kartika SariCentre for Public Health Innovation, Udayana University Faculty of Medicine, Denpasar, Bali, Indonesia.
Theresia Puspoarum KusumoputriCenter of Excellence for Health Policy and Social Innovation HIV AIDS Research Center, Atma Jaya Catholic University of Indonesia, South Jakarta, DKI Jakarta, Indonesia.
Ni Luh Putu AriastutiCentre for Public Health Innovation, Udayana University Faculty of Medicine, Denpasar, Bali, Indonesia.
Kevin KristianSchool of Medicine & Health Sciences, Atma Jaya Catholic University of Indonesia, North Jakarta, Special Capital Region of Jakarta, Indonesia.
Eric SindunataCenter of Excellence for Health Policy and Social Innovation HIV AIDS Research Center, Atma Jaya Catholic University of Indonesia, South Jakarta, DKI Jakarta, Indonesia.
Hendry LuisYayasan Bali Peduli, Bali, Indonesia.
Pande Putu JanuragaCentre for Public Health Innovation, Udayana University Faculty of Medicine, Denpasar, Bali, Indonesia.
Peter W HorbyISARIC Global Support Centre, Pandemic Sciences Institute, Oxford University, Oxford, UK.
Louise SigfridISARIC Global Support Centre, Pandemic Sciences Institute, Nuffield Department of Medicine, Oxford University, Oxford, Oxfordshire, UK.ORCID 0000-0003-2764-1177
Keerti GedelaChelsea and Westminster Hospital NHS Foundation Trust, London, UK k.gedela@nhs.net.ORCID 0000-0002-5797-8216

Funding

the Bill and Melinda Gates Foundation OPP1209135Wellcome Trust 215091/Z/18/Z
6 · The paper itself

Abstract

Chikungunya virus poses a significant public health challenge in Indonesia. Robust surveillance and diagnostics are lacking, and clinical management guidelines (CMGs) are absent.This practice article draws on insights from a qualitative health system stakeholder study conducted in Jakarta and Bali, Indonesia. The study examined barriers to the development and implementation of chikungunya CMGs.Findings reveal critical gaps in knowledge, diagnostic tools and prioritisation, exacerbated by systemic decentralisation and resource limitations. Robust, locally adapted CMGs could address these gaps, enhance clinical care and improve outbreak preparedness. This study underscores the importance of stakeholder engagement and capacity building in developing CMGs, offering lessons for low-resource settings managing emerging diseases.

Indexed as

Chikungunya FeverPractice Guidelines as TopicDisease OutbreaksHumansIndonesiaStakeholder ParticipationDescriptive studyHealth policyHealth systems evaluationInfections, diseases, disorders, injuriesPublic Health

Identifiers

PMID41708138
PMCPMC12918689

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.